tiprankstipranks
Trending News
More News >
Novavax (NVAX)
NASDAQ:NVAX
US Market

Novavax (NVAX) Income Statement

Compare
10,104 Followers

Novavax Income Statement

Last quarter (Q3 2025), Novavax's total revenue was $70.44M, a decrease of -16.64% from the same quarter last year. In Q3, Novavax's net income was $-202.38M. See Novavax’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 682.16M$ 556.38M$ 1.60B$ 197.58M$ 22.39M
Gross Profit
$ 479.42M$ 212.61M$ 696.31M$ 197.58M$ 22.39M
Operating Expenses
$ 728.35M$ 779.13M$ 1.34B$ 1.88B$ 439.11M
Depreciation and Amortization
$ 48.50M$ 41.23M$ 29.05M$ 12.66M$ 4.88M
EBITDA
$ -108.04M$ -487.39M$ -604.71M$ -1.68B$ -398.23M
Operating Income
$ -248.93M$ -566.51M$ -644.74M$ -1.69B$ -416.72M
Other Income/Expenses
$ 72.32M$ 23.48M$ -8.91M$ -27.96M$ -1.54M
Pretax Income
$ -176.62M$ -543.03M$ -653.65M$ -1.71B$ -418.26M
Net Income
$ -187.50M$ -545.06M$ -657.94M$ -1.74B$ -418.26M
Per Share Metrics
Basic EPS
$ -1.23$ -5.41$ -8.42$ -23.44$ -7.43
Diluted EPS
$ -1.23$ -5.41$ -8.42$ -23.44$ -7.43
Weighted Average Shares Outstanding
152.19M 100.77M 78.18M 74.40M 57.55M
Weighted Average Shares Outstanding (Diluted)
152.19M 100.77M 78.18M 74.40M 57.55M
Currency in USD

Novavax Earnings and Revenue History